September 8, 2021
Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies
August 27, 2021
EuropaBio response to the Public consultation on European bioeconomy policy: stocktaking and future developments
August 10, 2021
EuropaBio comments on the public consultation on blue bioeconomy
August 2, 2021
EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics
July 29, 2021
EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’
July 26, 2021
EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised
July 22, 2021
Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites
July 20, 2021
EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare
July 3, 2021
EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years
June 29, 2021
A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property
June 29, 2021
EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes
June 23, 2021
Interview with… Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana
June 23, 2021
Technology Park Ljubljana joins EuropaBio: better world through better technology
June 16, 2021
EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines
June 14, 2021
European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation
June 14, 2021
Novartis is proud to support the EuropaBio 25th Anniversary
June 9, 2021
Interview with Cyrille Pauthenier, CEO of Abolis Biotechnologies – The Bio-Synthesis Architects
June 7, 2021
EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities
June 7, 2021
Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines
June 1, 2021
EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future
May 31, 2021
EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021
May 27, 2021
EuropaBio welcomes the EU strategy on Covid-19 therapeutics
May 27, 2021
EuropaBio meets EMA to exchange views on topics of common interest
May 26, 2021
Enabling NGT products to contribute to sustainability: The role of Industrial Biotechnology
May 26, 2021
Inter-association letter to the EU Ministers of Agriculture and DG SANTE
May 25, 2021
Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation
May 20, 2021
EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments
May 20, 2021
Decentralised clinical trials, the future of clinical research
May 20, 2021
Advanced Therapies bring tranformational value to European patients
May 19, 2021
EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open
May 18, 2021
Interview with Bill Nankervis, Executive Vice President and Chief Operating Officer, Lallemand Group of Companies
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe

FOLLOW US HERE


Keep up with what is happening in the Biotech sector by connecting with us on social media!


facebook
twitter
instagram
linkedin
youtube
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
Become a member